Henry Silver

3.0k total citations
82 papers, 2.3k citations indexed

About

Henry Silver is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Henry Silver has authored 82 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Psychiatry and Mental health, 18 papers in Cognitive Neuroscience and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Henry Silver's work include Schizophrenia research and treatment (47 papers), Tryptophan and brain disorders (14 papers) and Neuroscience and Neuropharmacology Research (11 papers). Henry Silver is often cited by papers focused on Schizophrenia research and treatment (47 papers), Tryptophan and brain disorders (14 papers) and Neuroscience and Neuropharmacology Research (11 papers). Henry Silver collaborates with scholars based in Israel, United States and Germany. Henry Silver's co-authors include Warren B. Bilker, Ruben C. Gur, Craig Goodman, Ilan Modai, Victoria Isakov, Moussa B. H. Youdim, Orly Weinreb, Travis H. Turner, Michael S. Ritsner and Barry D. Berger and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Henry Silver

82 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Silver Israel 26 1.3k 593 458 443 327 82 2.3k
José Alvir United States 20 1.6k 1.2× 689 1.2× 372 0.8× 460 1.0× 214 0.7× 36 2.8k
Steven R. Hirsch United Kingdom 30 1.3k 1.0× 911 1.5× 487 1.1× 416 0.9× 326 1.0× 78 2.8k
Hans‐Jürgen Möller Germany 28 2.0k 1.5× 742 1.3× 420 0.9× 310 0.7× 241 0.7× 42 3.2k
Jean‐Pierre Olié France 31 1.5k 1.1× 731 1.2× 796 1.7× 350 0.8× 338 1.0× 109 2.8k
Hélio Elkis Brazil 26 1.4k 1.1× 574 1.0× 505 1.1× 246 0.6× 179 0.5× 105 2.2k
Henrik Lublin Denmark 25 1.3k 1.0× 438 0.7× 246 0.5× 392 0.9× 151 0.5× 59 2.0k
Lutz Schmidt Germany 27 1.0k 0.8× 467 0.8× 397 0.9× 594 1.3× 207 0.6× 66 2.4k
Emilio Fernández-Egea United Kingdom 33 1.5k 1.2× 723 1.2× 406 0.9× 362 0.8× 330 1.0× 131 3.1k
Arsime Demjaha United Kingdom 23 1.5k 1.2× 568 1.0× 522 1.1× 281 0.6× 302 0.9× 45 2.2k
Alain Labelle Canada 30 1.0k 0.8× 845 1.4× 312 0.7× 331 0.7× 166 0.5× 82 2.1k

Countries citing papers authored by Henry Silver

Since Specialization
Citations

This map shows the geographic impact of Henry Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Silver more than expected).

Fields of papers citing papers by Henry Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Silver. The network helps show where Henry Silver may publish in the future.

Co-authorship network of co-authors of Henry Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Silver. A scholar is included among the top collaborators of Henry Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Silver. Henry Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Sağlam, H., et al.. (2011). Clozapine Plasma Level Monitoring for Prediction of Rehospitalization Schizophrenic Outpatients. Pharmacopsychiatry. 44(2). 55–59. 15 indexed citations
4.
Silver, Henry, Warren B. Bilker, & Craig Goodman. (2009). Impaired recognition of happy, sad and neutral expressions in schizophrenia is emotion, but not valence, specific and context dependent. Psychiatry Research. 169(2). 101–106. 39 indexed citations
5.
6.
Silver, Henry & Michael Shmoish. (2008). Analysis of cognitive performance in schizophrenia patients and healthy individuals with unsupervised clustering models. Psychiatry Research. 159(1-2). 167–179. 29 indexed citations
7.
Weinreb, Orly, et al.. (2007). Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(7). 1356–1362. 23 indexed citations
8.
Silver, Henry & Craig Goodman. (2007). Impairment in error monitoring predicts poor executive function in schizophrenia patients. Schizophrenia Research. 94(1-3). 156–163. 20 indexed citations
9.
Goodman, Craig, et al.. (2005). Insight into illness in schizophrenia. Comprehensive Psychiatry. 46(4). 284–290. 34 indexed citations
10.
Weinreb, Orly, et al.. (2005). The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex. The International Journal of Neuropsychopharmacology. 9(3). 287–287. 26 indexed citations
11.
Hiemke, Christoph, A. Peled, Jack Hadjez, et al.. (2002). Fluvoxamine Augmentation of Olanzapine in Chronic Schizophrenia: Pharmacokinetic Interactions and Clinical Effects. Journal of Clinical Psychopharmacology. 22(5). 502–506. 51 indexed citations
12.
Silver, Henry, et al.. (2000). Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study. International Clinical Psychopharmacology. 15(5). 257–261. 78 indexed citations
13.
14.
Silver, Henry, et al.. (1995). Effects of Biperiden and Amantadine on Memory in Medicated Chronic Schizophrenic Patients. The British Journal of Psychiatry. 166(2). 241–243. 36 indexed citations
15.
Schwartz, M., et al.. (1993). Tardive Dyskinesia in Northern Israel: Preliminary Study. European Neurology. 33(3). 264–266. 6 indexed citations
16.
Silver, Henry, Daniella David, Jack Hadjez, et al.. (1993). Factor analysis of schizophrenic symptoms and comparison of different rating scales. Schizophrenia Research. 10(1). 67–75. 39 indexed citations
17.
Ebstein, Richard P., et al.. (1990). Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patients. Journal of Psychiatric Research. 24(2). 121–127. 10 indexed citations
18.
Lerer, Bernard, et al.. (1988). Neuroendocrine responses in chronic schizophreniaEvidence for serotonergic dysfunction. Schizophrenia Research. 1(6). 405–410. 45 indexed citations
19.
Silver, Henry. (1987). Physical complaints are part of the core depressive syndrome: evidence from a cross-cultural study in Israel.. PubMed. 48(4). 140–2. 16 indexed citations
20.
Silver, Henry. (1986). Physical complaints correlate better with depression than do dexamethasone suppression test results.. PubMed. 47(4). 179–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Alvir Breakdown of academic impact, for papers by Steven R. Hirsch Breakdown of academic impact, for papers by Hans‐Jürgen Möller Breakdown of academic impact, for papers by Jean‐Pierre Olié Breakdown of academic impact, for papers by Hélio Elkis Breakdown of academic impact, for papers by Henrik Lublin Breakdown of academic impact, for papers by Lutz Schmidt Breakdown of academic impact, for papers by Emilio Fernández-Egea Breakdown of academic impact, for papers by Arsime Demjaha Breakdown of academic impact, for papers by Alain Labelle
Rankless by CCL
2026